Covered recipient · General Payments record
KAREN E MUCHOWSKI
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$810.89
- Reported across 46 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $303.88 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $164.00 | 12 |
| Astellas Pharma US Inc | $61.56 | 2 |
| ABBVIE INC. | $32.95 | 1 |
| GlaxoSmithKline, LLC. | $22.98 | 1 |
| Organon LLC | $22.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.95 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105077023 | CMS |
| Astellas Pharma US Inc | $31.96 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139362777 | CMS |
| Astellas Pharma US Inc | $29.60 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139356029 | CMS |
| GlaxoSmithKline, LLC. | $22.98 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116213190 | CMS |
| Novo Nordisk Inc | $22.16 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097254921 | CMS |
| Novo Nordisk Inc | $19.43 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097411366 | CMS |
| Novo Nordisk Inc | $16.61 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096710885 | CMS |
| Novo Nordisk Inc | $11.13 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097022779 | CMS |
| Novo Nordisk Inc | $18.20 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096600311 | CMS |
| Novo Nordisk Inc | $7.35 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097489612 | CMS |
| Novo Nordisk Inc | $22.39 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096606039 | CMS |
| Novo Nordisk Inc | $6.22 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096826199 | CMS |
| Novo Nordisk Inc | $24.26 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097554491 | CMS |
| Novo Nordisk Inc | $5.85 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096932419 | CMS |
| Novo Nordisk Inc | $5.08 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097552070 | CMS |
| Novo Nordisk Inc | $5.32 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097514418 | CMS |
| Organon Llc | $22.39 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136252571 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.